-
Swimmers McKeown, O'Callaghan and Chalmers dominate at Australian Open
-
Bucha: When the Russian killers came...
-
Iran, a Terrorist State with No Right to Exist
-
African players in Europe: Semenyo scores as City rout Liverpool
-
Israeli strikes kill Iran Guards intel chief as Trump deadline looms
-
Saving energy in everyday life or a complete rip-off?
-
US sprint star Richardson wins Australia's Stawell Gift in record time
-
Rockets down Warriors in Curry return, Flagg carries Mavs past Lakers
-
Artemis mission approaches lunar loop for first flyby since 1972
-
Israeli rescuers search for missing in building strike, two dead
-
Defiant Iran ramps up attacks after Trump warning
-
Saudi oasis town adjusts to life in the firing line
-
Pogacar stays humble with Monument history beckoning
-
Real Madrid hoping Champions League magic halts Bayern juggernaut
-
Sputtering Arsenal face test of character in Sporting clash
-
'Not the Cairo we know': Energy shock from Iran war dims Egypt nights
-
Tokyo, Seoul shares gain, war sends oil higher
-
Artemis mission headed for first lunar flyby since 1972
-
South Korea president says regrets 'reckless' drones sent to North
-
Coughlin captures third LPGA title at Aramco Championship
-
What to know about the Artemis 2 mission's Moon flyby
-
Mystique of the green jacket endures as Masters looms
-
In El Salvador's mass trials, 'the innocent pay for the guilty'
-
Trump makes stark threat to Iran after US airman rescued
-
Bora Biologics Successfully Completes 2,000L Engineering and Scale-Up Run in San Diego, Reinforcing Commercial-Scale Readiness
-
Avino Announces Normal Course Issuer Bid for Common Shares
-
Revolve Signs Interconnection Agreement for 130 MW EL 24 Wind Project in Mexico
-
Building the Moon's Future: Helio Positioned at the Center of America's Lunar Strategy for the Dawn of the Artemis Era
-
Trumps FDA CBD Enforcement Shift Signals a Turning Point - Why MMJ International Holdings is the Sector's Opportunity
-
Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference
-
Texas Gulf Bank, N.A. Appoints Chase Zalman President
-
Bioz and Vilber Advance Evidence-Driven Scientific Marketing with Custom Publication Integration
-
Artemis astronauts ready for Moon flyby on fifth day of historic mission
-
Israel renews Lebanon strikes, forces Syria border crossing closed
-
Eagle-eyed Spaun snatches Texas Open victory
-
Brown, Tatum propel Celtics in win over Raptors
-
Paul battles past Burruchaga to win ATP Houston title
-
Major sponsors drop Kanye West London gigs as PM voices concern
-
Inter close in on Serie A title by thumping Roma
-
Trump makes foul-mouthed threat to Iran after US airman rescued
-
Monaco sink Marseille for seventh Ligue 1 win in a row
-
Inter thump Roma to extend Serie A lead to nine points
-
Lebanon's Christians mark Easter in solidarity with war-hit south
-
Leeds beat West Ham in shoot-out to reach FA Cup semis for first time in 39 years
-
Pegula romps to WTA Charleston Open victory
-
David six-hitting spree powers Bengaluru to IPL win
-
Union draw leaves St Pauli stranded in Bundesliga drop zone
-
UK police arrest protesters near base used by US
-
Trump issues foul-mouthed threat to Iran after US airman rescued
-
Alcaraz plans to play full clay-court season, get 'socks dirty'
T-Mobile USA, Inc. Enters into a Strategic Multi-Year Agreement with Amdocs to Support Its Customer Experience and Operational Excellence Journey
The new agreement extends the long-term relationship and includes managed services, software development, AI innovation, and UScellular integration
JERSEY CITY, NJ / ACCESS Newswire / February 3, 2026 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today announced the extension of its long-standing strategic collaboration with T-Mobile USA, Inc. through a new multi-year agreement supporting T-Mobile's continued growth and operational excellence.
Under the new agreement, T-Mobile and Amdocs will collaborate to support T-Mobile's growth strategy and business objectives. Amdocs will continue to support T-Mobile's consumer and business domains, including implementation of GenAI technology where applicable. As part of this agreement, Amdocs will be leveraged to support integration activities related to common systems.
"Amdocs is proud to support T-Mobile USA, Inc. providing robust solutions and expertise to enable agility, efficiency, and growth," said Anthony Goonetilleke, Group President of Technology and Head of Strategy at Amdocs. "We are excited to deepen our collaboration as T-Mobile USA, Inc. continues to transform its operations and customer experience. Together, we're advancing the future of connectivity and customer engagement, setting new standards in the industry."
Supporting Resources
Keep up with Amdocs news by visiting the company's website
About T-Mobile USA, Inc.
T-Mobile US, Inc. (NASDAQ: TMUS) is America's supercharged Un-carrier, delivering an advanced 4G LTE and transformative nationwide 5G network that offers reliable connectivity for all. T-Mobile's customers benefit from its unmatched combination of value and quality, unwavering obsession with offering the best possible service experience, and undisputable drive for disruption that creates competition and innovation in wireless and beyond. For more information, visit www.t-mobile.com
About Amdocs
Amdocs helps the world's leading communications and media companies deliver exceptional customer experiences through reliable, efficient, and secure operations at scale. We provide software products and services that embed intelligence into how work runs across business, IT, and network domains - delivering measurable outcomes in customer experience, network performance, cloud modernization, and revenue growth. With our talented people, and more than 40 years of experience running mission-critical systems around the globe, Amdocs runs billions of transactions daily. Our technology is relied on every day, connecting people worldwide and advancing a more inclusive, connected world. Together, we help those who shape the future to make it amazing. Amdocs is listed on the NASDAQ Global Select Market (NASDAQ: DOX) and reported revenue of $4.53 billion in fiscal 2025. For more information, visit www.amdocs.com.
Amdocs' Forward-Looking Statement
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other regional events or pandemics, changes to trade policies including tariffs and trade restrictions, as well as the current inflationary environment, and the effects of these conditions on the Company's customers' businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company's customers. Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, security incidents, including breaches and cyberattacks to our systems and networks and those of our partners or customers, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the Company's offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs' filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2025, filed on December 15, 2025.
Media Contacts
Mario Hajiloizi
Amdocs Public Relations
E-mail: [email protected]
SOURCE: Amdocs Management Limited
View the original press release on ACCESS Newswire
R.Chavez--AT